-
PD for Fri 13 Feb 2026
Friday | Feb 13 2026Clinical guideline for MDMA addresses uncertainty and misinformation, patients call for more accessible pharmacies, new role for Fei Sim, and more
-
College celebrates 50 years
Thursday | Feb 12 2026THE Australasian College of Pharmacy marked 50 years of leadership, education and professional excellence with a celebration dinner held in Brisbane on Tue night.
-
IPA awards retail excellence
Thursday | Feb 12 2026INDEPENDENT Pharmacies Australia (IPA) hosted its second annual Retail Excellence Awards on Mon evening, with five team members celebrated for their best-in-class commitment to pharmacy excellence.
-
Editor’s Choice: Wake up to visibly repaired skin and lips
Thursday | Feb 12 2026IN partnership with Dermal Therapy
-
Pharma taking PBAC to court over knockback
Thursday | Feb 12 2026PERTH-BASED Lawley Pharmaceuticals has lodged an application in the Federal Court of Australia seeking judicial review of the decision by the Pharmaceutical Benefits Advisory Committee (PBAC) in Nov 2025 to not recommend listing of AndroFeme 1, a transdermal testosterone cream formulated for post-menopausal women, on the PBS (PD 06 Jan).
-
Cert III and IV courses review
Thursday | Feb 12 2026THREE community pharmacy qualifications are being reviewed and updated to ensure they reflect the current and future needs of the sector, with draft training products now open for public consultation.
-
SMS vax ‘nudge’ improves uptake
Thursday | Feb 12 2026A SIMPLE text message to remind parents of upcoming vaccinations could potentially see an additional 35,000 kids getting their 18-month and four-year-old shots on time, according to Australian research published in Lancet Regional Health today.
-
Arrotex, Pfizer team up on Enbrel
Thursday | Feb 12 2026ARROTEX Pharmaceuticals and Pfizer Australia have inked a new strategic commercial partnership, under which Arrotex will represent Enbrel (etanercept) across Australian community and hospital pharmacy channels, as well as prescriber channels.
-
CSL slumps in 1H FY26, CEO out
Thursday | Feb 12 2026CSL has recorded substantial losses in first half year 2026 financial results reported yesterday, with earnings down 81% after it was forced to write down the value of its assets by $1.6 billion.
-
Hair and beauty trends
Thursday | Feb 12 2026FROM biomimetic peels to metallic makeup, the winners of the Australian Beauty Industry Awards have shared their trend predictions for 2026 with Beauty Directory.
PARTNER SITES
to top